Draft label contains both PAH and PH-ILD indications; no contraindications and no boxed warning
Complete response cites an open inspection issue at a third-party analytical testing facility; no other deficiencies cited
Approval and launch expected in summer 2022 or earlier
PR Newswire
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2021